Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anatara Lifesciences Ltd (AU:ANR)
:ANR
Holding AU:ANR?
Track your performance easily
ANR Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.07
Previous CloseN/A
Volume35.84K
Average Volume (3M)58.83K
Market Cap
AU$12.16M
Enterprise ValueAU$6.62M
Total Cash (Recent Filing)$5.41M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.79
Next Earnings
Feb 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding213,383,730
10 Day Avg. Volume35,141
30 Day Avg. Volume58,828
Standard Deviation0.22
R-Squared0.07
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)9.82
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap0.54
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Anatara Lifesciences Ltd News
PremiumCompany Announcements
Anatara Lifesciences Advances GaRP-IBS Trial and Expands Portfolio
PremiumCompany Announcements
Anatara Lifesciences Issues New Unlisted Options
PremiumCompany Announcements
Anatara Lifesciences Director Increases ShareholdingPremiumCompany Announcements
Anatara Lifesciences Updates Investors on Health Product Progress
PremiumCompany Announcements
Anatara Lifesciences Secures Funding for Key ProjectsPremiumCompany Announcements
Anatara Lifesciences Pauses Trial Recruitment, Eyes Future Growth
PremiumCompany Announcements
Anatara Lifesciences Advances GaRP-IBS Clinical Trial
PremiumCompany Announcements
Anatara Lifesciences Hosts Webinar on New InitiativesOptions Prices
Currently, No data available
---
Ownership Overview
ANR FAQ
What was Anatara Lifesciences Ltd’s price range in the past 12 months?
Anatara Lifesciences Ltd lowest share price was AU$0.02 and its highest was AU$0.07 in the past 12 months.
What is Anatara Lifesciences Ltd’s market cap?
Anatara Lifesciences Ltd’s market cap is AU$12.16M.
When is Anatara Lifesciences Ltd’s upcoming earnings report date?
Anatara Lifesciences Ltd’s upcoming earnings report date is Feb 19, 2025 which is in 31 days.
How were Anatara Lifesciences Ltd’s earnings last quarter?
Anatara Lifesciences Ltd released its earnings results on Aug 28, 2024. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.004.
Is Anatara Lifesciences Ltd overvalued?
According to Wall Street analysts Anatara Lifesciences Ltd’s price is currently Overvalued.
Does Anatara Lifesciences Ltd pay dividends?
Anatara Lifesciences Ltd does not currently pay dividends.
What is Anatara Lifesciences Ltd’s EPS estimate?
Anatara Lifesciences Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anatara Lifesciences Ltd have?
Anatara Lifesciences Ltd has 213,383,730 shares outstanding.
What happened to Anatara Lifesciences Ltd’s price movement after its last earnings report?
Anatara Lifesciences Ltd reported an EPS of -AU$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -20%.
Which hedge fund is a major shareholder of Anatara Lifesciences Ltd?
Currently, no hedge funds are holding shares in AU:ANR
---
Anatara Lifesciences Ltd Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:ANR Sentiment 70%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth AU$30.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
163.63%
12-Months-Change
Fundamentals
Return on Equity
-126.79%
Trailing 12-Months
Asset Growth
17.76%
Trailing 12-Months
Company Description
Anatara Lifesciences Ltd
Anatara Lifesciences Ltd is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. The company develops Detach, a natural, plant-based product that prevents and treats diarrhea in production animals. It generates its income from license revenue.
---
Technical Analysis
Prescient Therapeutics Limited
―
Race Oncology Ltd.
―
Alcidion Group Limited
―
Hexima Ltd
―
Propanc Biopharma
―
---